• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐带血移植:改善植入和免疫重建的演进策略。

Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution.

机构信息

Adult Stem Cell Transplant Program, Division of Hematology/Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, USA.

出版信息

Curr Opin Oncol. 2010 Mar;22(2):122-9. doi: 10.1097/cco.0b013e328335a56e.

DOI:10.1097/cco.0b013e328335a56e
PMID:20180284
Abstract

PURPOSE OF REVIEW

For many patients with relapsed or high-risk hematologic malignancies, allogeneic stem cell transplantation offers the best hope for cure. For patients lacking a suitable family or unrelated donor, umbilical cord blood provides a promising alternative graft source. Dramatic advances in cord blood transplantation (CBT) have been made in the past 2 decades, leading to a rapid expansion of CBT programs worldwide.

RECENT FINDINGS

Promising new strategies, including double CBT and ex-vivo graft engineering, have improved myeloid and platelet engraftment rates and kinetics. However, delayed immune reconstitution and associated infectious morbidity and mortality remain a significant challenge, especially in adult CBT recipients. In adults, both impaired recipient thymopoiesis and the lack of transferred memory cells contribute to delayed T cell recovery, resulting in an increased risk of opportunistic infections.

SUMMARY

Novel clinical approaches in CBT have improved outcomes, especially those associated with delays in myeloid and platelet engraftment. However, delayed immune reconstitution remains a great challenge. Novel strategies, including graft engineering approaches capable of improving T cell recovery, and pharmacologic interventions capable of preserving thymopoiesis and facilitating the recovery of a diverse functional T cell repertoire are being pursued; these approaches have great potential to further improve outcomes after CBT.

摘要

目的综述

对于许多复发或高危血液系统恶性肿瘤患者来说,异基因造血干细胞移植是治愈的最佳希望。对于缺乏合适的家庭供者或无关供者的患者,脐带血提供了一种有前途的替代移植物来源。在过去的 20 年中,脐带血移植(CBT)取得了显著进展,导致全球 CBT 项目迅速扩张。

最新发现

有前途的新策略,包括双 CBT 和体外移植物工程,提高了髓系和血小板植入率和动力学。然而,延迟的免疫重建以及由此导致的感染发病率和死亡率仍然是一个重大挑战,特别是在成人 CBT 受者中。在成人中,受者胸腺生成受损和缺乏转移的记忆细胞都导致 T 细胞恢复延迟,从而增加了机会性感染的风险。

总结

CBT 中的新临床方法改善了结果,特别是那些与髓系和血小板植入延迟相关的结果。然而,延迟的免疫重建仍然是一个巨大的挑战。目前正在探索新的策略,包括能够改善 T 细胞恢复的移植物工程方法,以及能够保存胸腺生成和促进多样化功能 T 细胞库恢复的药物干预措施;这些方法有很大的潜力进一步改善 CBT 后的结果。

相似文献

1
Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution.脐带血移植:改善植入和免疫重建的演进策略。
Curr Opin Oncol. 2010 Mar;22(2):122-9. doi: 10.1097/cco.0b013e328335a56e.
2
Umbilical cord blood transplantation.脐带血移植
Clin Adv Hematol Oncol. 2010 Nov;8(11):786-801.
3
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.血液系统恶性肿瘤无关供者脐血移植的最佳实践
Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. doi: 10.1016/j.bbmt.2017.03.006. Epub 2017 Mar 6.
4
Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.30例成人血液系统恶性肿瘤患者接受非血缘供者脐带血移植的临床结局
Anticancer Res. 2009 May;29(5):1763-70.
5
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.脐带血移植后延迟免疫重建的特征是胸腺生成受损和晚期记忆性T细胞偏移。
Blood. 2007 Dec 15;110(13):4543-51. doi: 10.1182/blood-2007-05-092130. Epub 2007 Aug 1.
6
Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.血液系统恶性肿瘤患者接受无关供者脐带血移植与骨髓或外周血造血干细胞移植的疗效比较:单中心分析。
Chin Med J (Engl). 2013 Jul;126(13):2499-503.
7
Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults.来自无关供体的脐带血细胞作为儿童和成人造血干细胞移植的替代来源。
Semin Hematol. 2016 Oct;53(4):237-245. doi: 10.1053/j.seminhematol.2016.08.002. Epub 2016 Aug 15.
8
Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.评估高压氧治疗改善脐血植入的试点研究的长期结果。
Ann Hematol. 2019 Feb;98(2):481-489. doi: 10.1007/s00277-018-3532-1. Epub 2018 Oct 31.
9
Improving outcomes in umbilical cord blood transplantation: state of the art.改善脐带血移植的结局:现状。
Blood Rev. 2012 Nov;26(6):241-6. doi: 10.1016/j.blre.2012.08.001. Epub 2012 Sep 5.
10
Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.通过体外扩增或移植物处理改善脐带血移植的疗效。
Cytotherapy. 2015 Jun;17(6):730-738. doi: 10.1016/j.jcyt.2015.02.004. Epub 2015 Mar 14.

引用本文的文献

1
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.脐带血移植治疗非恶性疾病:早期功能性免疫和高存活率。
Blood Adv. 2023 May 9;7(9):1823-1830. doi: 10.1182/bloodadvances.2022009038.
2
Engineering cord blood to improve engraftment after cord blood transplant.改造脐带血以改善脐带血移植后的植入情况。
Stem Cell Investig. 2017 May 25;4:41. doi: 10.21037/sci.2017.05.01. eCollection 2017.
3
Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood.
实现从脐带血快速产生靶向BK病毒、腺病毒、巨细胞病毒和EB病毒的多病毒特异性T细胞。
Mol Ther Methods Clin Dev. 2017 Mar 8;5:13-21. doi: 10.1016/j.omtm.2017.02.001. eCollection 2017 Jun 16.
4
Decreases in thymopoiesis of astronauts returning from space flight.航天员从太空飞行返回后胸腺生成减少。
JCI Insight. 2016 Aug 4;1(12):e88787. doi: 10.1172/jci.insight.88787.
5
Discovery of novel INK4C small-molecule inhibitors to promote human and murine hematopoietic stem cell ex vivo expansion.发现新型 INK4C 小分子抑制剂以促进人和鼠造血干细胞的体外扩增。
Sci Rep. 2015 Dec 18;5:18115. doi: 10.1038/srep18115.
6
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.双份脐血移植后的全身及病毒特异性免疫细胞重建
Biol Blood Marrow Transplant. 2015 Jul;21(7):1284-90. doi: 10.1016/j.bbmt.2015.02.017. Epub 2015 Feb 20.
7
Improving engraftment and immune reconstitution in umbilical cord blood transplantation.提高脐带血移植中的植入率和免疫重建水平。
Front Immunol. 2014 Feb 24;5:68. doi: 10.3389/fimmu.2014.00068. eCollection 2014.
8
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.巨核细胞促进骨髓放射损伤后小鼠成骨祖细胞龛的扩增和干细胞植入。
Blood. 2013 Jun 27;121(26):5238-49. doi: 10.1182/blood-2012-10-463414. Epub 2013 May 10.
9
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.成人患者在接受清髓性双脐带血、匹配同胞供者和匹配无关供者造血细胞移植后的免疫重建。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1664-1676.e1. doi: 10.1016/j.bbmt.2012.06.005. Epub 2012 Jun 12.
10
The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.脐带:丰富而符合伦理的干细胞来源,推动再生医学发展。
Cell Prolif. 2011 Apr;44 Suppl 1(Suppl 1):60-9. doi: 10.1111/j.1365-2184.2010.00729.x.